UBS Group
MR

UBS Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

UBS Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-400,000
Closed -$10.6M – 9916
2014
Q4 		$10.6M Buy
+400,000
New +$11.7M 0.01% 1465

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group's MR Position: Q1 2016 in Review

UBS Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 792,261 shares — an estimated $21.5M sold.

UBS Group first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $24.9M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • UBS Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • UBS Group sold 792,261 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $21.5M.
  • UBS Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
  • UBS Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $24.9M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on UBS Group's 13F filing for Q1 2016, filed 12 May 2016.